View on Pubmed.gov 34158963 | View on doi.org 10.1177/2054358...
Assessment of Kidney Function After Transcatheter Aortic Valve Replacement.
- Department of Nephrology, Tel Aviv Medical Center, Sackler School of Medicine, Tel Aviv University, Israel.
- Department of Cardiology, Tel Aviv Medical Center, Sackler School of Medicine, Tel Aviv University, Israel.
Abstract
BACKGROUND
Transcatheter aortic valve replacement (TAVR), although associated with an increased risk for acute kidney injury (AKI), may also result in improvement in renal function.
OBJECTIVE
The aim of this study is to evaluate the magnitude of kidney function improvement (KFI) after TAVR and to assess its significance on long-term mortality.
DESIGN
This is a prospective single center study.
SETTING
The study was conducted in cardiology department, interventional unit, in a tertiary hospital.
PATIENTS
The cohort included 1321 patients who underwent TAVR.
MEASUREMENTS
Serum creatinine level was measured at baseline, before the procedure, and over the next 7 days or until discharge.
METHODS
Kidney function improvement was defined as the mirror image of AKI, a reduction in pre-procedural to post-procedural minimal creatinine of more than 0.3 mg/dL, or a ratio of post-procedural minimal creatinine to pre-procedural creatinine of less than 0.66, up to 7 days after the procedure. Patients were categorized and compared for clinical endpoints according to post-procedural renal function change into 3 groups: KFI, AKI, or preserved kidney function (PKF). The primary endpoint was long-term all-cause mortality.
RESULTS
The incidence of KFI was 5%. In 55 out of 66 patients patients, the improvement in kidney function was minor and of unclear clinical significance. Acute kidney injury occurred in 19.1%. Estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m was a predictor of KFI after multivariable analysis (odds ratio = 0.93 to develop KFI; confidence interval [95% CI]: 0.91-0.95, < .001). Patients in the KFI group had a higher Society of Thoracic Surgery (STS) score than other groups. Mortality rate did not differ between KFI group and PKF group (43.9% in KFI group and 33.8% in PKF group) but was significantly higher in the AKI group (60.7%, < .001).
LIMITATIONS
The following are the limitations: heterozygous definitions of KFI within different studies and a single center study. Although data were collected prospectively, analysis plan was defined after data collection.
CONCLUSIONS
Improvement in kidney function following TAVR was not a common phenomenon in our cohort and did not reduce overall mortality rate.
References
JAMA Cardiol. 2017 Jul 1;2(7):742-749
Eur Heart J. 2017 Sep 21;38(36):2739-2791
Kidney Int. 2017 Jun;91(6):1312-1323
Am J Cardiol. 2018 May 15;121(10):1239-1245
Cited by 2 citations (total)
Journal Article
Acute Kidney Injury Following Transcatheter Aortic Valve Implantation: Association with Contrast Media Dosage and Contrast Media Based Risk Predication Models.
Electronic publication date March 11, 2022
Doron Sudarsky [...] Ibrahim Marai et al.
The effect of contrast media (CM), delivered prior to- and during transcatheter aortic valve implantation (TAVI), on kidney function, following...
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Ariel Finkelstein is a consultant for Medtronic and Edwards Lifesciences. Amir Halkin is a consultant for Abbott Laboratories and Boston Scientific. All other authors declare having no potential conflicts of interest.
MeSH
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
Copyright
© The Author(s) 2021.